Literature DB >> 12212964

Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study.

V I Peinado1, S Santos, J Ramírez, J Roca, R Rodriguez-Roisin, J A Barberà.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) show impaired hypoxic pulmonary vasoconstriction that might contribute to abnormal gas exchange and could be related to endothelial dysfunction in pulmonary arteries. The aim of the study was to investigate the response of PA to hypoxic stimulus in vitro in COPD, and the role of endothelium-derived nitric oxide (NO) in this response. The pulmonary arteries of 25 patients who underwent lung resection were studied. Patients were divided into controls, COPD+normoxaemia (COPDN) and COPD+ hypoxaemia (COPDH). Hypoxic vasoconstriction (HV) was evaluated before and after stimulation or inhibition of the endothelial release of NO, and in the presence of exogenous NO. Compared with the other groups, HV was reduced in COPDH. The magnitude of HV correlated with the oxygen tension in arterial blood. The hypoxic stimulus induced greater contraction after stimulating endothelial release of NO, whereas its inhibition practically abolished HV. Exogenous NO completely inhibited HV. Maximal relaxation induced by endothelium-dependent vasodilators correlated with the magnitude of HV. In conclusion, pulmonary arteries of patients with chronic obstructive pulmonary disease and hypoxaemia have an impaired response to hypoxic stimulus, and the endothelial release of nitric oxide modulates hypoxic vasoconstriction. The depressed response of pulmonary arteries to hypoxia may contribute to abnormal gas exchange in chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12212964     DOI: 10.1183/09031936.02.00282002

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Exposure of mice to chronic hypoxia attenuates pulmonary arterial contractile responses to acute hypoxia by increases in extracellular hydrogen peroxide.

Authors:  Dhara Patel; Raed Alhawaj; Michael S Wolin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-11       Impact factor: 3.619

Review 2.  Impact of hypoxia on male reproductive functions.

Authors:  P A Oyedokun; R E Akhigbe; L O Ajayi; A F Ajayi
Journal:  Mol Cell Biochem       Date:  2022-09-15       Impact factor: 3.842

Review 3.  Group 3 Pulmonary Hypertension: From Bench to Bedside.

Authors:  Navneet Singh; Peter Dorfmüller; Oksana A Shlobin; Corey E Ventetuolo
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

Review 4.  Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.

Authors:  Joan Albert Barberà; Isabel Blanco
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

5.  Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgery: A randomised double-blinded trial.

Authors:  Su Hyun Lee; Namo Kim; Chang Yeong Lee; Min Gi Ban; Young Jun Oh
Journal:  Eur J Anaesthesiol       Date:  2016-04       Impact factor: 4.330

6.  Pulmonary Arterial Pressure Response During Exercise in COPD: A Correlation with C-Reactive Protein (hsCRP).

Authors:  Janos Varga; Attila Palinkas; Imre Lajko; Ildikó Horváth; Krisztina Boda; Attila Somfay
Journal:  Open Respir Med J       Date:  2016-01-29

Review 7.  Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.

Authors:  Tomas Rajtik; Peter Galis; Linda Bartosova; Ludovit Paulis; Eva Goncalvesova; Jan Klimas
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

8.  Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension.

Authors:  Joan Albert Barberà
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.